Pasithea Therapeutics Cor... (KTTA)
NASDAQ: KTTA
· Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.48%
After-hours: Aug 15, 2025, 07:01 PM EDT
Pasithea Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 5.34M | 6.92M | 9.36M | 7.97M | 12.01M | 16.33M | 19.58M | 26.65M | 29.91M | 33.15M | 42.4M | 47.94M | 50.32M | 52.97M | 20.57M | 568.98K | 1.07M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.11M | 619.29K | -11.1M | n/a | -4.41M | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | 40.5K | n/a | n/a | 15.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | -40.5K | -40.5K | 985.07K | 814.57K | 920.48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 162.45K | 142.94K | 98.33K | 104.65K | 145.15K | 145.21K | 201.51K | 574.7K | 347.69K | 426.45K | 865.99K | 79.59K | n/a | n/a | n/a | 282.86K | n/a |
Total Current Assets | 6.12M | 7.37M | 9.78M | 8.64M | 13.19M | 16.69M | 20.77M | 28.04M | 31.11M | 34.08M | 44.47M | 48.61M | 50.95M | 53.3M | 21.03M | 924.76K | 1.14M |
Property-Plant & Equipment | 117.52K | 122.34K | 127.06K | 131.78K | 168.52K | 220.48K | 524.38K | 593.18K | 635.45K | 1.25M | 1.27M | 579.95K | 128.62K | 20.12K | 8.57K | n/a | n/a |
Goodwill & Intangibles | 8.42M | 8.57M | 8.73M | 8.89M | 9.05M | 9.2M | 9.36M | 9.52M | 9.68M | 9.85M | 3.87M | 3.83M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.53M | 8.7M | 8.86M | 9.02M | 9.22M | 9.42M | 9.89M | 10.11M | 10.93M | 11.1M | 5.14M | 4.41M | 128.62K | 20.12K | 8.57K | n/a | n/a |
Total Assets | 14.66M | 16.06M | 18.64M | 17.66M | 22.41M | 26.12M | 30.66M | 38.15M | 42.04M | 45.18M | 49.61M | 53.03M | 51.08M | 53.32M | 21.04M | 924.76K | 1.14M |
Account Payables | n/a | n/a | n/a | 1.39M | 2.43M | 2.55M | 1.87M | 1.93M | 1.45M | 1.48M | 1.26M | 848.69K | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | -2.43M | -2.55M | -1.87M | -1.93M | -1.45M | -1.61M | -258.03K | -848.69K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 133.34K | 264.1K | n/a | 258.03K | 101.42K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.59M | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | 245.54K | 235.88K | -258.03K | -101.42K | 433.68K | 447.28K | 528.1K | 454.68K | n/a |
Total Current Liabilities | 1.59M | 1.12M | 660.4K | 1.39M | 2.47M | 2.63M | 2.04M | 2.23M | 2.12M | 1.88M | 1.51M | 950.11K | 433.68K | 447.28K | 528.1K | 454.68K | 239.45K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 85.31K | 162.17K | 163.58K | 93.27K | 57.65K | 84.36K | 29.06K | 74.06K | 487.15K | 460.19K | 581.12K | 245.8K | 667.5K | 1.45M | 4.04M | n/a | n/a |
Total Long-Term Liabilities | 85.31K | 162.17K | 163.58K | 93.27K | 57.65K | 84.36K | 239.88K | 330.14K | 787.63K | 804.21K | 1.31M | 604.05K | 667.5K | 1.45M | 4.04M | n/a | n/a |
Total Liabilities | 1.68M | 1.28M | 823.98K | 1.49M | 2.52M | 2.72M | 2.28M | 2.56M | 2.91M | 2.68M | 2.82M | 1.55M | 1.1M | 1.9M | 4.57M | 454.68K | 239.45K |
Total Debt | n/a | n/a | n/a | n/a | 32.99K | 81.68K | 385.29K | 559.1K | 729.56K | 926.89K | 982.42K | 459.66K | n/a | n/a | n/a | n/a | n/a |
Common Stock | 270.00 | 139.00 | 104K | 104.00 | 104.00 | 104.00 | 17.47K | 18K | 18K | 17.99K | 18.04K | 18.05K | 17.68K | 17.68K | 16.7K | 16.21K | 16.21K |
Retained Earnings | -53.15M | -49.58M | -46.41M | -43.05M | -39.18M | -35.32M | -30.27M | -26.66M | -22.89M | -19.36M | -11.03M | -6.45M | -3.79M | -2.21M | -2.84M | -1.32M | -590.59K |
Comprehensive Income | n/a | -7.17K | -35.32K | -8.18K | -5.27K | -4.65K | -7.72K | -3.46K | -3.14K | -661 | -146.57K | -64.06K | -15.07K | -10.56K | -3.76K | -2.31K | n/a |
Shareholders Equity | 12.98M | 14.78M | 17.81M | 16.18M | 19.88M | 23.4M | 28.37M | 35.59M | 39.14M | 42.5M | 46.79M | 51.47M | 49.98M | 51.42M | 16.48M | 470.08K | 900.67K |
Total Investments | n/a | n/a | 9.35B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |